The French-American Chamber of Commerce is hosting an event on challenges and opportunities in personalized medicine, the first in a series of events on biotech. Richard Mitchell, the director of business development at the Fred Hutchinson Cancer Research Center, will moderate a panel discussion that features Paul Yager and Wylie Burke of the University of Washington, Howard Coleman of Genelex, Bassem Beijani of Signature Genomics, and Sam Webb of Stoel Rives. For more information on how to register, click here.